ANAIS DURAN

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

In support of more funding and support for at risk girls, including in Commerce, Justice, Science Appropriations bills. In support of the JJDPA Reauthorization Act, S. 1169.

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Military Justice Improvement Act (originally S.1752 in 113th Congress) National Defense Authorization Act (NDAA)